These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 6417640)

  • 21. [Approaches to combined therapy of pulmonary tuberculosis in adolescents excreting drug-resistant Mycobacterium tuberculosis].
    Firsova VA; Rusakova LI; Grigor'eva ZP; Ryzhova AP; Iatskova TV; Poluéktova FG
    Probl Tuberk; 2001; (1):28-30. PubMed ID: 11337776
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Methods of determining the bacteriostatic activity of the blood and the primary drug resistance of mycobacteria in pulmonary tuberculosis].
    Bibik NF
    Probl Tuberk; 1980 Feb; (2):63-6. PubMed ID: 6769111
    [No Abstract]   [Full Text] [Related]  

  • 23. Development of a microdilution method to evaluate Mycobacterium tuberculosis drug susceptibility.
    Banfi E; Scialino G; Monti-Bragadin C
    J Antimicrob Chemother; 2003 Nov; 52(5):796-800. PubMed ID: 14519676
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antimicrobial susceptibility testing of Mycobacterium tuberculosis to first-line drugs: comparisons of the MGIT 960 and BACTEC 460 systems.
    Huang TS; Tu HZ; Lee SS; Huang WK; Liu YC
    Ann Clin Lab Sci; 2002; 32(2):142-7. PubMed ID: 12017195
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Terminal causes of death in patients suffering from pulmonary tuberculosis in relation to the drug sensitivity of the strains of Mycobacterium tuberculosis].
    Daddi G; Lucchesi M; Mancini P; Rossi P; Sbampato M; Storniello G
    Ann Ist Carlo Forlanini; 1969; 29(4):339-48. PubMed ID: 5004332
    [No Abstract]   [Full Text] [Related]  

  • 26. [Efficacy of chemotherapy of pulmonary tuberculosis drug-resistant m.tuberculosis].
    Khomenko AG; Chukanov VI; Korneev AA
    Probl Tuberk; 1996; (6):42-4. PubMed ID: 9019768
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anti-tuberculosis drug resistance and HIV co-infection in Phnom Penh, Cambodia.
    Sar B; Keo C; Leng C; Saman M; Min DC; Chan S; Monchy D; Sarthou JL
    Southeast Asian J Trop Med Public Health; 2009 Jan; 40(1):104-7. PubMed ID: 19323041
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Current possibilities of the use of the so-called minor antimycobacterial agents].
    Grassi C
    G Ital Mal Torace; 1971; 25(6):301-12. PubMed ID: 5005062
    [No Abstract]   [Full Text] [Related]  

  • 29. [Relationship between the susceptibility testing of Mycobacterium avium complex strains and the clinical efficacy of antituberculosis drugs--an evidence suggesting that antituberculosis drugs are effective in the treatment of M. avium complex pulmonary infection].
    Tsukamura M; Ichiyama S; Miyachi T
    Kekkaku; 1988 Apr; 63(4):227-31. PubMed ID: 3404801
    [No Abstract]   [Full Text] [Related]  

  • 30. [Evaluation of secondary chemoresistance of Koch bacillus at the present time].
    Jemna I; Lego I
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1981; 30(4):243-4. PubMed ID: 6278569
    [No Abstract]   [Full Text] [Related]  

  • 31. [Relapses in pulmonary tuberculosis. Value of the case history for the selection of the best retreatment regimen].
    Pilheu JA; de Salvo MC; Gnecco V; Giannattasio J; Hoffman M
    Medicina (B Aires); 1982; 42(4):389-95. PubMed ID: 15171020
    [No Abstract]   [Full Text] [Related]  

  • 32. [Rapid detection and assessment of drug susceptibility of Mycobacterium tuberculosis].
    Hu ZY
    Zhonghua Jie He He Hu Xi Za Zhi; 2003 Feb; 26(2):107-9. PubMed ID: 12795287
    [No Abstract]   [Full Text] [Related]  

  • 33. Rapid and simple MTT method for rifampicin and isoniazid susceptibility testing of Mycobacterium tuberculosis.
    Foongladda S; Roengsanthia D; Arjrattanakool W; Chuchottaworn C; Chaiprasert A; Franzblau SG
    Int J Tuberc Lung Dis; 2002 Dec; 6(12):1118-22. PubMed ID: 12546122
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Drug resistance of Mycobacterium tuberculosis in coniotuberculosis].
    Beskrovnyĭ PS; Varenko IuS; Lastkov OA
    Vrach Delo; 1981 Aug; (8):72-4. PubMed ID: 6791383
    [No Abstract]   [Full Text] [Related]  

  • 35. Antimycobacterial drugs.
    Heifets LB
    Semin Respir Infect; 1994 Jun; 9(2):84-103. PubMed ID: 7973175
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Drug resistance of Mycobacterium tuberculosis and its significance in the hospital practice].
    Rudoĭ NM
    Probl Tuberk; 1996; (3):6-8. PubMed ID: 8754863
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Statistical evaluation of the dependence of chemotherapeutical success upon the frequency of bacteriological resistance tests].
    Kühler F
    Beitr Klin Erforsch Tuberk Lungenkr; 1969; 140(1):106-9. PubMed ID: 4980953
    [No Abstract]   [Full Text] [Related]  

  • 38. [Comparative study of bactec MGIT 960 AST and conventional proportion method using Ogawa medium for the drug susceptibility testing of Mycobacterium tuberculosis to isoniazid].
    Mitarai S; Kobayashi I; Abe C; Wada M; Suzuki K; Takashima T; Kawabe Y; Machida K; Tano M; Takigawa S; Kamada A; Shigetoh E; Fujii S; Mori K; Suyama H; Yano S; Kawashiro T; Ogata H
    Kekkaku; 2007 May; 82(5):449-54. PubMed ID: 17564123
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New generation methods for drug susceptibility testing for tuberculosis.
    Katoch VM
    Indian J Tuberc; 2008 Apr; 55(2):61-3. PubMed ID: 18516820
    [No Abstract]   [Full Text] [Related]  

  • 40. Incidence of multidrug-resistant tuberculosis in urban and rural India and implications for prevention.
    Almeida D; Rodrigues C; Udwadia ZF; Lalvani A; Gothi GD; Mehta P; Mehta A
    Clin Infect Dis; 2003 Jun; 36(12):e152-4. PubMed ID: 12802779
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.